ID   PA2GF_HUMAN             Reviewed;         168 AA.
AC   Q9BZM2; Q5R385; Q8N217; Q9H506;
DT   11-FEB-2002, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-2001, sequence version 1.
DT   10-MAY-2017, entry version 136.
DE   RecName: Full=Group IIF secretory phospholipase A2;
DE            Short=GIIF sPLA2;
DE            Short=sPLA2-IIF;
DE            EC=3.1.1.4;
DE   AltName: Full=Phosphatidylcholine 2-acylhydrolase 2F;
DE   Flags: Precursor;
GN   Name=PLA2G2F;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, CATALYTIC ACTIVITY,
RP   COFACTOR, SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RC   TISSUE=Fetal lung, Heart, and Spleen;
RX   PubMed=11112443; DOI=10.1006/bbrc.2000.3908;
RA   Valentin E., Singer A.G., Ghomashchi F., Lazdunski M., Gelb M.H.,
RA   Lambeau G.;
RT   "Cloning and recombinant expression of human group IIF-secreted
RT   phospholipase A(2).";
RL   Biochem. Biophys. Res. Commun. 279:223-228(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Thymus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I.S., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S.I., Hart E., Haugen E., Heath P.D.,
RA   Holmes S., Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G.,
RA   Isherwood J., James R., Johnson C., Johnson D., Joy A., Kay M.,
RA   Kershaw J.K., Kibukawa M., Kimberley A.M., King A., Knights A.J.,
RA   Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M.,
RA   Loveland J., Lovell J., Lush M.J., Lyne R., Martin S.,
RA   Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., McLaren S.,
RA   Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C.,
RA   Subramanian S., Sycamore N., Tracey A., Tromans A., Van Helmond Z.,
RA   Wall M., Wallis J.M., White S., Whitehead S.L., Wilkinson J.E.,
RA   Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z., Coulson A.,
RA   Vaudin M., Sulston J.E., Durbin R.M., Hubbard T., Wooster R.,
RA   Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V.,
RA   Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
CC   -!- FUNCTION: PA2 catalyzes the calcium-dependent hydrolysis of the 2-
CC       acyl groups in 3-sn-phosphoglycerides. Hydrolyzes
CC       phosphatidylglycerol versus phosphatidylcholine with a 15-fold
CC       preference. {ECO:0000269|PubMed:11112443}.
CC   -!- CATALYTIC ACTIVITY: Phosphatidylcholine + H(2)O = 1-
CC       acylglycerophosphocholine + a carboxylate. {ECO:0000255|PROSITE-
CC       ProRule:PRU10035, ECO:0000269|PubMed:11112443}.
CC   -!- COFACTOR:
CC       Name=Ca(2+); Xref=ChEBI:CHEBI:29108;
CC         Evidence={ECO:0000269|PubMed:11112443};
CC       Note=Binds 1 Ca(2+) ion per subunit.
CC       {ECO:0000269|PubMed:11112443};
CC   -!- SUBCELLULAR LOCATION: Secreted {ECO:0000269|PubMed:11112443}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q9BZM2-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9BZM2-2; Sequence=VSP_037524;
CC   -!- TISSUE SPECIFICITY: Expressed at high levels in placenta, testis,
CC       thymus and at lower levels in heart, kidney, liver and prostate.
CC       {ECO:0000269|PubMed:11112443}.
CC   -!- SIMILARITY: Belongs to the phospholipase A2 family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF306566; AAG50242.1; -; mRNA.
DR   EMBL; AK093645; BAC04210.1; -; mRNA.
DR   EMBL; AL158172; CAI19658.1; -; Genomic_DNA.
DR   EMBL; Z98257; CAI19658.1; JOINED; Genomic_DNA.
DR   EMBL; Z98257; CAI20260.1; -; Genomic_DNA.
DR   EMBL; AL158172; CAI20260.1; JOINED; Genomic_DNA.
DR   CCDS; CCDS204.2; -. [Q9BZM2-2]
DR   RefSeq; NP_073730.3; NM_022819.3. [Q9BZM2-2]
DR   RefSeq; XP_011540258.1; XM_011541956.1. [Q9BZM2-2]
DR   UniGene; Hs.302034; -.
DR   ProteinModelPortal; Q9BZM2; -.
DR   SMR; Q9BZM2; -.
DR   IntAct; Q9BZM2; 3.
DR   STRING; 9606.ENSP00000364243; -.
DR   BindingDB; Q9BZM2; -.
DR   ChEMBL; CHEMBL4278; -.
DR   GuidetoPHARMACOLOGY; 1420; -.
DR   SwissLipids; SLP:000000654; -. [Q9BZM2-1]
DR   iPTMnet; Q9BZM2; -.
DR   PhosphoSitePlus; Q9BZM2; -.
DR   BioMuta; PLA2G2F; -.
DR   DMDM; 20139134; -.
DR   PaxDb; Q9BZM2; -.
DR   PeptideAtlas; Q9BZM2; -.
DR   PRIDE; Q9BZM2; -.
DR   DNASU; 64600; -.
DR   Ensembl; ENST00000375102; ENSP00000364243; ENSG00000158786. [Q9BZM2-2]
DR   GeneID; 64600; -.
DR   KEGG; hsa:64600; -.
DR   UCSC; uc009vpp.2; human. [Q9BZM2-1]
DR   CTD; 64600; -.
DR   DisGeNET; 64600; -.
DR   GeneCards; PLA2G2F; -.
DR   H-InvDB; HIX0000212; -.
DR   HGNC; HGNC:30040; PLA2G2F.
DR   neXtProt; NX_Q9BZM2; -.
DR   OpenTargets; ENSG00000158786; -.
DR   PharmGKB; PA134931043; -.
DR   eggNOG; KOG4087; Eukaryota.
DR   eggNOG; ENOG411283D; LUCA.
DR   GeneTree; ENSGT00760000119160; -.
DR   HOGENOM; HOG000231749; -.
DR   HOVERGEN; HBG008137; -.
DR   InParanoid; Q9BZM2; -.
DR   KO; K01047; -.
DR   OMA; LNETECD; -.
DR   OrthoDB; EOG091G0UZ3; -.
DR   PhylomeDB; Q9BZM2; -.
DR   TreeFam; TF319283; -.
DR   Reactome; R-HSA-1482788; Acyl chain remodelling of PC.
DR   Reactome; R-HSA-1482801; Acyl chain remodelling of PS.
DR   Reactome; R-HSA-1482839; Acyl chain remodelling of PE.
DR   Reactome; R-HSA-1482922; Acyl chain remodelling of PI.
DR   Reactome; R-HSA-1482925; Acyl chain remodelling of PG.
DR   Reactome; R-HSA-1483166; Synthesis of PA.
DR   GenomeRNAi; 64600; -.
DR   PRO; PR:Q9BZM2; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   Bgee; ENSG00000158786; -.
DR   CleanEx; HS_PLA2G2F; -.
DR   Genevisible; Q9BZM2; HS.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0005576; C:extracellular region; TAS:Reactome.
DR   GO; GO:0005509; F:calcium ion binding; IEA:InterPro.
DR   GO; GO:0004623; F:phospholipase A2 activity; TAS:Reactome.
DR   GO; GO:0050482; P:arachidonic acid secretion; IEA:InterPro.
DR   GO; GO:0016042; P:lipid catabolic process; IEA:UniProtKB-KW.
DR   GO; GO:0042130; P:negative regulation of T cell proliferation; IEA:Ensembl.
DR   GO; GO:0006654; P:phosphatidic acid biosynthetic process; TAS:Reactome.
DR   GO; GO:0036151; P:phosphatidylcholine acyl-chain remodeling; TAS:Reactome.
DR   GO; GO:0036152; P:phosphatidylethanolamine acyl-chain remodeling; TAS:Reactome.
DR   GO; GO:0036148; P:phosphatidylglycerol acyl-chain remodeling; TAS:Reactome.
DR   GO; GO:0036149; P:phosphatidylinositol acyl-chain remodeling; TAS:Reactome.
DR   GO; GO:0036150; P:phosphatidylserine acyl-chain remodeling; TAS:Reactome.
DR   CDD; cd00125; PLA2c; 1.
DR   Gene3D; 1.20.90.10; -; 1.
DR   InterPro; IPR001211; PLipase_A2.
DR   InterPro; IPR016090; PLipase_A2_dom.
DR   InterPro; IPR033113; PLipase_A2_His_AS.
DR   PANTHER; PTHR11716; PTHR11716; 1.
DR   Pfam; PF00068; Phospholip_A2_1; 1.
DR   PRINTS; PR00389; PHPHLIPASEA2.
DR   SMART; SM00085; PA2c; 1.
DR   SUPFAM; SSF48619; SSF48619; 1.
DR   PROSITE; PS00118; PA2_HIS; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Calcium; Complete proteome; Disulfide bond;
KW   Glycoprotein; Hydrolase; Lipid degradation; Lipid metabolism;
KW   Metal-binding; Reference proteome; Secreted; Signal.
FT   SIGNAL        1     20       {ECO:0000255}.
FT   CHAIN        21    168       Group IIF secretory phospholipase A2.
FT                                /FTId=PRO_0000022759.
FT   ACT_SITE     67     67       {ECO:0000255|PROSITE-ProRule:PRU10035}.
FT   ACT_SITE    114    114       {ECO:0000255|PROSITE-ProRule:PRU10035}.
FT   METAL        47     47       Calcium; via carbonyl oxygen.
FT                                {ECO:0000250}.
FT   METAL        49     49       Calcium; via carbonyl oxygen.
FT                                {ECO:0000250}.
FT   METAL        51     51       Calcium; via carbonyl oxygen.
FT                                {ECO:0000250}.
FT   METAL        68     68       Calcium. {ECO:0000250}.
FT   CARBOHYD     92     92       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    102    102       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    123    123       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    144    144       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID     46    138       {ECO:0000250}.
FT   DISULFID     48     64       {ECO:0000250}.
FT   DISULFID     63    120       {ECO:0000250}.
FT   DISULFID     69    145       {ECO:0000250}.
FT   DISULFID     70    113       {ECO:0000250}.
FT   DISULFID     79    106       {ECO:0000250}.
FT   DISULFID     98    111       {ECO:0000250}.
FT   VAR_SEQ       1      1       M -> MADGAKANPKGFKKKVLDRCFSGWRGPRFGASCPSR
FT                                TSRSSLGM (in isoform 2). {ECO:0000305}.
FT                                /FTId=VSP_037524.
FT   CONFLICT    149    149       E -> G (in Ref. 2; BAC04210).
FT                                {ECO:0000305}.
SQ   SEQUENCE   168 AA;  18658 MW;  35B159298246A762 CRC64;
     MKKFFTVAIL AGSVLSTAHG SLLNLKAMVE AVTGRSAILS FVGYGCYCGL GGRGQPKDEV
     DWCCHAHDCC YQELFDQGCH PYVDHYDHTI ENNTEIVCSD LNKTECDKQT CMCDKNMVLC
     LMNQTYREEY RGFLNVYCQG PTPNCSIYEP PPEEVTCSHQ SPAPPAPP
//
